assembled.
Science

Former US FDA Official Li Zili Appointed to Lead Hong Kong's New Medical Products Regulator

Li Zili, a former official at the US Food and Drug Administration (FDA), has been appointed to lead Hong Kong's new medical products body for a three-year term, aiming to accelerate the clinical use of medicines and medical devices.

Editorial illustration symbolizing the leadership of a new medical products regulator overseeing advanced medical technology.
AI-generated illustration

According to the South China Morning Post, Li Zili, who has a background as a former official at the US Food and Drug Administration (FDA), has been appointed to lead Hong Kong's new medical products body. The government announced on Monday that Li Zili will serve as the controller for medical products regulation under the Department of Health for a three-year term commencing on October 20.

Li Zili is set to lead the Centre for Medical Products Regulation, which is scheduled to be established later in the year. This new body is tasked with promoting proactive "primary evaluation," expediting the clinical application of drugs and medical devices, and ensuring that patients have access to advanced products that adhere to established quality and safety standards.

Keep reading

More Science